Skip to main content
Equibles

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1165408 Boston, MA
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,903,000
+$12,680,400 QoQ
Shares Held
510,000
+5000.0% QoQ
Ownership
0.296%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#45
of 354 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. ACAD ranks #70 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 10,349,328 $366,262,717
2 PRAX
Praxis Precision Medicines, Inc.
 1,015,480 $339,972,549
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 393,964 $195,693,737
4 TNGX
Tango Therapeutics, Inc.
 5,600,000 $175,056,000
5 BBIO
BridgeBio Pharma, Inc.
 2,252,000 $167,728,960
6 SYRE
Spyre Therapeutics, Inc.
 1,722,300 $152,905,794
7 TVTX
Travere Therapeutics, Inc.
 2,569,356 $145,965,114
8 RPRX
Royalty Pharma plc
 2,500,000 $140,175,000

All Filings in ACAD

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,903,000 510,000
2026-03-31 $222,600 10,000
2025-12-31 $244,556 9,156
2025-09-30 $53,011,889 2,484,156
2025-06-30 $13,023,966 603,800
2023-06-30 $85,096,577 3,553,093
2023-03-31 $23,054,500 1,225,000
2020-12-31 $4,276,800 80,000